Skip to content

Drug interactions

Cyclophosphamide + Fondaparinux

Severity: Moderate

Cyclophosphamide and Fondaparinux: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Thrombocytopenia from cyclophosphamide adds to the bleeding risk of fondaparinux. Bleeding risk is highest when platelet counts are low or renal function is impaired.

What this interaction means in plain words

Cyclophosphamide and Fondaparinux can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cyclophosphamide belongs to Oncology; Fondaparinux belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive bleeding risk from chemotherapy-induced thrombocytopenia combined with factor Xa inhibition.

What to do

Monitor platelet counts and renal function, and hold or reduce fondaparinux when platelets are significantly low or bleeding occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cyclophosphamide and Fondaparinux, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cyclophosphamide with Fondaparinux?

MediHelp rates the interaction as moderate. Cyclophosphamide and Fondaparinux can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Thrombocytopenia from cyclophosphamide adds to the bleeding risk of fondaparinux. Bleeding risk is highest when platelet counts are low or renal function is impaired.

How serious is the interaction between Cyclophosphamide and Fondaparinux?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor platelet counts and renal function, and hold or reduce fondaparinux when platelets are significantly low or bleeding occurs.

What other medicines interact with Cyclophosphamide?

MediHelp also lists interactions of Cyclophosphamide with, for example, Adenovirus types 4 and 7 live, Belatacept, Bendamustine. The full list is on the Cyclophosphamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in